The application was based on results from the three-arm Phase 3 CheckMate -8HW study.

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today reported ...

Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts epoxides into fluorinated oxetanes, a coveted but difficult-to-make class of ...

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

Years ago, he had a good-paying job working from home as an accountant. But isolated from the office, he said he fell into a depression and began to lose himself in a shady corner of the dark web ...

Addiction Recovery Care plans to operate two residential treatment centers in the county, one for men and the other for women ...

They’re already among the most sought-after institutions in the world by patients, and for many of the same reasons they’re ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Political and business leaders are rethinking AI—as not just a technology to regulate but as a force to accelerate. Medicine ...

Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.